Current and Upcoming Opportunities
Despite a wealth of potential, the bioactive materials from the world's marine organisms and ecosystems remain largely unexplored. The third ERA-MBT call for applications “Metagenomic approaches for valorization from the marine environment” seeks to stimulate international collaborations combining research strengths in marine b…
GeneSolve is a new program beginning in January 2017 that supports projects providing solutions challenges from users across industry sectors. This user driven program is unique in that it encourages a collaborative research approach between industry users and academia.
This funding opportunity will be aimed at supporting projects that will demonstrate how genomics-based research can contribute to a more evidence-based approach to health and, thereby, improve health outcomes, and/or enhance the cost-effectiveness of the healthcare system.
The goal of the Sector Innovation Program is to support projects that will address the needs of each key sector and have the potential to generate social, environmental and economic benefits for British Columbia in the future.
Does your company have a clear pathway to commercialization for an innovative life science technology? Learn more about Genome BC's I² Fund that provides early stage commercialization support for companies developing BC-based technologies
Genome Canada and SSHRC Joint Initiative on Societal Implications of Disruptive Innovation in Genomics
Genome Canada (GC) and the Social Sciences and Humanities Research Council (SSHRC) have signed a joint initiative agreement to jointly support social sciences and humanities research and related activities pertaining to genomics, with one of the first initiatives focusing on societal implications of disruptive innovation in geno…
The Genomic Applications Partnership Program (GAPP) represents a key element in Genome Canada’s strategic plan towards funding downstream research and development (R&D) projects that are driven by challenges and opportunities facing users of genomics based technologies.